Method of manufacturing nanostructure with improved cell adhesive ability containing fucoidan and nanostructure with improved cell adhesive ability containing fucoidan manufactured thereby

US10968346B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10968346-B2
Application numberUS-201916299835-A
CountryUS
Kind codeB2
Filing dateMar 12, 2019
Priority dateSep 13, 2016
Publication dateApr 6, 2021
Grant dateApr 6, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method of manufacturing a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan according to the present invention comprises dissolving fucoidan in glacial acetic acid as a solvent to obtain fucoidan-glacial acetic acid solution, mixing polycaprolactone with the fucoidan-glacial acetic acid solution to obtain a polycaprolactone-mixed solution, and manufacturing a nanostructure from the polycaprolactone-mixed solution by an electrospinning method. Therefore, a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured by the method according to the present invention exhibits characteristics of preventing fucoidan from being released from nanofibers by uniformly distributing fucoidan in the polycaprolactone nanostructure. Accordingly, the fucoidan-containing polycaprolactone nanostructure exhibits an effect capable of controlling cell activity while culturing adhered cells by facilitating adhesion of various types of cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of manufacturing a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan, the method comprising the steps of: dissolving fucoidan in distilled water to obtain fucoidan-dissolved distilled water, and mixing the fucoidan-dissolved distilled water with a glacial acetic acid solution to obtain a fucoidan-glacial acetic acid solution; dissolving polycaprolactone in the fucoidan-glacial acetic acid solution to obtain a solution; stirring the solution at a temperature of 35 to 40° C. for 12 hours to obtain a resulting solution; and manufacturing a nanostructure from the solution by an electrospinning method, wherein, the fucoidan-glacial acetic acid solution obtained by the step of mixing the fucoidan-dissolved distilled water with a glacial acetic acid solution comprises 0.5 to 1 mg/ml of fucoidan. 2. The method of claim 1 , wherein the step of manufacturing a nanostructure from the solution by an electrospinning method comprises manufacturing a nanostructure from the solution by an electrospinning method at a voltage of 8 to 10 KV and a spinning speed of 8 to 10 μg/min. 3. A polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured according to the method of claim 1 . 4. A polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured according to the method of claim 2 .

Assignees

Inventors

Classifications

  • characterised by the electro-spinning apparatus · CPC title

  • Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides · CPC title

  • from polymer solutions · CPC title

  • A61L27/18Primary

    obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10968346B2 cover?
The present invention relates to a method of manufacturing a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan according to the present invention comprises dissolving fucoidan in glacial acetic acid as a solvent to obtain fucoidan-glacial acetic acid solution, mixing polycaprolactone with the fucoidan-glacial acetic acid solution to obtain a polycaprolactone…
Who is the assignee on this patent?
Univ Ajou Ind Academic Coop Found
What technology area does this patent fall under?
Primary CPC classification A61L27/18. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).